Radiomics-based models to predict IDH mutation status and prognosis in gliomas using MRI: a multicenter study

Read full text
Authors: Esra Sümer-Arpak, Ayca Ersen Danyeli, M. Cengiz Yakicier, M. Necmettin Pamir, Koray Özduman, Alp Di̇nçer, Esin Ozturk-Isik
Cited by: 1
References: 56

Abstract

Introduction: Gliomas are infiltrative primary intracranial tumors with marked biological and clinical heterogeneity. Prognosis varies widely and depends on tumor grade, histopathological characteristics, and molecular alterations. Isocitrate dehydrogenase mutation is a key prognostic biomarker and is associated with improved treatment response and longer overall survival. Radiomics enables the extraction of quantitative features from routinely acquired medical images. This study evaluated radiomics-based machine learning models for noninvasive prediction of isocitrate dehydrogenase mutation status and overall survival in glioma patients. Methods: From T2-weighted MRI scans of 638 gliomas (213 from a local institution (discovery), 425 from a public dataset (validation)), 1,820 radiomics features were extracted. Machine learning models were constructed and trained on the discovery cohort and externally validated to predict isocitrate dehydrogenase mutation status. A radiomics risk score was computed using Lasso regression, and patients were stratified into high- and low-risk groups using the median radiomics risk score for Kaplan-Meier analysis. Cox regression assessed the prognostic value of radiomics risk score along with clinical features (age, sex, WHO grade, isocitrate dehydrogenase mutation status). A nomogram incorporating independent predictors to estimate 1-, 2-, and 3-year overall survival was assessed using the concordance index and calibration curves. Results: Logistic regression and random forest classifier models achieved area under the receiver operating characteristic curve of 0.90 and 0.68 in the discovery and validation cohorts, respectively, for isocitrate dehydrogenase mutation prediction using 12 top radiomic features. High-risk patients showed significantly shorter median overall survival than low-risk patients in both discovery and validation cohorts (21 vs. 30 months, 10 vs. 19.5 months, respectively; P

Fields of Study & Subjects

Glioma Diagnosis and Treatment Radiomics and Machine Learning in Medical Imaging Brain Tumor Detection and Classification

Publication details

Journal / source
Frontiers in Oncology
Publisher
Frontiers Media SA
Volume
16
Pages
1775958–1775958
Publication date
27 March 2026
Language
EN